MARSEILLE, France, Nov. 2, 2015 (GLOBE NEWSWIRE) -- VECT-HORUS, a biotechnology company that designs and develops peptide vectors for addressing drugs or imaging agents to the brain and other organs, announces the strengthening of its patent portfolio with the granting of two patents in several major countries and particularly in the United States.
These two patents protect peptide vectors that facilitate the targeting of drugs or imaging agents to organs, including the brain. Entitled "Peptide Derivatives and Use Thereof as Carriers for Molecules in the Form of Conjugates" and "Peptide Derivatives, Preparation Thereof and Uses Thereof", these two patents have been issued in the United States under No. US 8729029 and US 8877716, respectively.
The first patent was filed in 2008 and has since been granted in Europe, South Africa and Eurasia. Furthermore, a notice of allowance was received from Australia, China and Japan. A further extension of this patent claiming optimized vectors was also filed in several countries, including the United States.
The second patent was filed in 2010 and has since been granted in Eurasia and France.
Read more: http://www.globenewswire.com/news-release/2015/11/02/782284/10154803/en/VECT-HORUS-Two-new-patents-protecting-VECTrans-R-technology-issued-in-several-major-countries.html